Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926276 · ClinicalTrials.gov registry record · Phase 4
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT00926276 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 2 participants.
The verdict
NCT00926276, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of fundoplication in premature infants with GERD and BPD.
Interventions
- PROCEDURE Fundoplication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00926276
The ClinicalTrials.gov registry entry for NCT00926276 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fundoplication is the first listed.
NCT00926276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00926276 about?
NCT00926276 is a clinical study titled "The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia". The purpose of this study is to evaluate the efficacy of fundoplication in premature infants with GERD and BPD.
What is the current status of trial NCT00926276?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2009-06. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00926276?
The interventions under investigation include: Fundoplication (PROCEDURE).
Who is sponsoring clinical trial NCT00926276?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.